Help find a cure for Alzheimer’s disease by volunteering for our Alzheimer’s clinical trial. Your participation will save lives and help our scientists develop new medications to prevent the progression of this debilitating disease.

A life-changing chance to make a global impact

Without inspirational people like you taking part in Alzheimer’s, dementia and memory loss trials, new medications cannot be licensed for global use. This is because the sponsor needs to demonstrate the efficacy and safety of the medication. By volunteering, you’ll create a phenomenally positive impact on millions of people across the world and create a better quality of life for them. 

If someone has a diagnosis of Alzheimer’s Disease I would say get in touch with Re:Cognition Health: they are doing excellent work and look after you so well throughout the processStudy partner of clinical trial volunteer

Let’s stop the alarmingly high rates of Alzheimer’s & dementia

Over 1 million people in the UK will have a diagnosis of dementia by 2025, according to the Alzheimer’s Society. By 2051 this number is expected to exceed 2 million. It’s estimated that 82 million people worldwide will be suffering from dementia by 2030.

You can help reduce these figures! Sign up to volunteer today and help find a cure for Alzheimer’s. 

Current treatments for Alzheimer’s

The death of brain cells in Alzheimer’s is currently unstoppable, so the only medications available to be prescribed are ‘symptomatic’. These medications only manage the symptoms of dementia, as opposed to delaying its progression. 

Symptomatic drugs work to help the dying brain cells function better but, as the disease progresses, more and more brain cells die, leading to a greater decline in cognitive functioning. See common signs of memory loss here.

Do I need to be diagnosed with Alzheimer’s?

No. As part of the screening, we aim to identify the issue behind each patient’s memory concerns. This stretches further than just an MRI or CT Scan. We perform a much more in-depth scan called an amyloid PET scan. This identifies if patients have a build-up of Alzheimer-related plaque in their brains. 

It’s only those who are positive that can go on to study. Patients never even have to go on study if they prove to be positive for this plaque. You can just continue your previous care if you would like.

Trialling effective new treatments

Trailblazing volunteers for our clinical trial have the opportunity to access new drugs designed to prevent the progression of memory impairment. These drugs are called ‘disease-modifying treatments’. They aim to keep the brain cells alive in order to reduce the progression of memory impairment. 

How do disease-modifying treatments work?

Disease-modifying treatments work to reduce the levels of B amyloid & Tau Protein in the brain and alter genetic and inflammatory markers. They are believed to be much more effective than the current medications and are available as part of the clinical trials at our clinics.

One Clinical Trial, One Life-Changing Opportunity

Our research is led by Dr Emer MacSweeney, an international expert in the field of Alzheimer’s research. Share our passion for finding a cure for Alzheimer’s disease by taking part in our study.

Watch Dr Emer MacSweeney talk about clinical trials with Primal Cure below. 


What is a clinical trial?

Clinical trials are necessary to develop new treatments and improve existing ones, and they are conducted under strict guidelines to ensure the safety of study participants. A clinical trial uses human volunteers to evaluate the new treatment’s safety, effectiveness, and potential side effects. Paracetamol, ibuprofen, aspirin & many other common medicines all went through clinical trials at one stage! 

Clinical trials are conducted in various phases, each with a specific objective, to gather data and evaluate the safety and efficacy of a medical treatment. 

The phases of clinical trials typically include:

  1. Phase 0: This is the exploratory phase, where researchers test very small doses of a drug or treatment to see if it behaves in the body as expected.
  2. Phase I: This is the safety phase, where the focus is on determining the safety of a drug or treatment and the best dose to give patients.
  3. Phase II: This is the efficacy phase, where researchers evaluate the effectiveness of the treatment and monitor any side effects.
  4. Phase III: This is the confirmation phase, where researchers confirm the effectiveness and safety of the treatment in a larger group of patients.
  5. Phase IV: This is the post-marketing phase, where researchers continue to monitor the long-term safety and effectiveness of the treatment after it has been approved by regulatory authorities and made available to the public.

Our clinical trials start at Phase II

We don’t run Phase I trials at our clinics; the medication used in our trials has been given to humans in previous studies. We’re currently in Phase II of our new treatment to test its effectiveness and monitor any side effects. 

Find out what process you’ll go through when you volunteer for us.

Benefits of joining this clinical trial

  • Complimentary refreshments
  • Travel expenses are reimbursed for each visit
  • Access specialist private healthcare and avoid lengthy NHS waiting lists
  • Help develop dementia syndrome and memory loss treatments for future generations
  • Early access to new treatments for memory loss and you are monitored closely throughout the trial
  • Outstanding medical care provided at no cost, including comprehensive health screens, MRI scans and PET scans


Without inspirational people taking part in Alzheimer’s, dementia and memory loss trials, new medications cannot be licensed for global use. This is because the sponsor needs to demonstrate the efficacy and safety of the medication. Even paracetamol went through a clinical trial at one stage!

We don’t run phase 1 trials at our clinics and the study medication has been given to humans in previous studies.

Potential benefits of joining a clinical trial

  • Study volunteers get early access to new treatments for memory loss and are monitored closely throughout the trial
  • Outstanding medical care is provided at no cost, including comprehensive health screens, MRI scans and PET scans
  • The chance to avoid lengthy NHS waiting lists and access specialist private healthcare
  • Travel expenses are reimbursed for each visit and complimentary refreshments are available
  • Volunteers have the opportunity to help develop dementia syndrome and memory loss treatments for future generations

International efforts to find better treatments

The fight against Alzheimer’s disease is spearheaded by international clinical trials that provide hope through early access to disease-modifying Alzheimer’s treatments.

There are lots of studies open across the world investigating the effectiveness of new medications. To find out which study might be right for you, or somebody you know, speak to a specialist today.

Volunteer for our dementia clinical trial. Test an investigational medication to see if it might improve cognitive function, including attention, memory, and language in patients who have dementia with Lewy bodies (DLB). Learn more here 

Find a cure for Alzheimer’s & change the world

To join our Alzheimer’s clinical trial, simply sign up here. Discover more benefits & what you can access when you volunteer for us. Alternatively, call our friendly team on 0800 802 1030 to sign-up. 

Frequently Asked Questions

Will I be paid?

Volunteers are not paid for taking part in this Alzheimer’s research.

However, the sponsor will reimburse reasonable travel expenses for you and your study partner for each visit.

To give you an example, for most of our current trials, the reimbursement is up to £60 for the volunteer and £60 for the study partner for each visit.

How often are the visits?

This depends on the research study you participate in. The screening period of the study is generally when the visits are most frequent. This is when all the initial investigations are carried out to confirm whether a volunteer is eligible for a study.

During the treatment stage of the study, the visits will be less frequent. Some studies require a clinic visit once a month whereas others have visits every six 6 weeks. If you do enrol onto a study, we’ll be able to give you all of your appointments in advance. 

Can I leave the trial before it finishes?

Absolutely. Leaving a study will in no way affect your  medical or legal rights. It’s not necessary to give us a reason as to why you want to leave, although we always value any feedback from you. If you choose to leave after you have started taking the study drug, then we are obliged to offer you a final visit, to carry out final medical investigations to ensure your safety,

Will I get my results?

Yes. You will be informed of all of your results and your GP will also be made aware of any significant results.

Volunteers receive comprehensive medical care in the study so you can be assured that your health will be closely monitored. These include a medical examination, blood pressure reading, urine tests, ECG, MRI head scan, a PET scan or lumbar puncture. Our team are very experienced and are always available to discuss your participation with you.

Will I have to take a trial drug?

Yes. If you are found to be eligible for one of the clinical trials, then you can consent to be assigned to a treatment group. Depending on the trial, the trial medication can be in the form of a tablet taken orally once a day or an intravenous infusion once a month.

Will I know what I am taking?

No. You will not know whether you are taking the active study drug or a placebo. A placebo is a dummy pill and doesn’t contain any active drug. You will be randomly assigned into one of the study groups and you and your study team will not know which group you are in. This is called a randomised, double-blind, placebo controlled trial.

What if I am on placebo?

There is a chance that you are in the placebo group, the probability of that will depend on the trial. It may be anywhere between 1:2 to 1:3. Whichever group you are in, you will still benefit from the ongoing medical care and psychometric testing that you will receive as part of the trial.

At the end of the trial period, most trials offer the opportunity for you to enter the open label extension. This is when you continue in the trial but on the active drug despite whichever group (ie. Placebo or active drug) group you were in before. The open label extension is un-blinded, so you will know you are on the active drug.

Are there any side effects?

Any potential side effects will be listed in the patient information sheets that are sent to you prior to your initial consultation. Most of the side effects are non-specific but some trials have specific side effects that your study doctor will discuss with you. We will work closely with you and your GP to ensure your safety at all times.

What is a study partner and why do I need one?

A study partner is someone who can accompany the participant to some study visits and answer questions about their symptoms. They should be someone who sees the volunteer regularly e.g. a spouse, relative or close friend as they will need to let us know about any potential changes in the volunteer’s health or behaviour. The number of visits they need to attend depends on each study.

Do I need to tell my GP?

Yes and no. It is good practice to let your GP know but it is not necessary to inform your GP before your screening visit. If you are found to be eligible for the study at the screening visit, we will inform your GP and obtain a medical summary letter from your GP with your consent. We can also write to other doctors involved in your care should you wish.

Where can I take part?

Re:Cognition Health has clinics across the UK in London, Guildford, Plymouth and Birmingham. We’ve also just opened our first clinic in the USA! You can learn more about us here